Journal
BIOMOLECULES
Volume 13, Issue 10, Pages -Publisher
MDPI
DOI: 10.3390/biom13101558
Keywords
acute pancreatitis; metabolomics; lipidomics; glycerophospholipids; glycerolipids; fatty acyls; sterol lipids; biomarkers
Categories
Ask authors/readers for more resources
This study utilized serum metabolomics to identify potential diagnostic markers for acute pancreatitis (AP) and distinguish between its different etiologies. The research provides insights into the metabolic landscape of AP and highlights the potential for new diagnostic biomarkers and therapeutic strategies.
Acute pancreatitis (AP) remains a challenging medical condition, where a deeper metabolic insight could pave the way for innovative treatments. This research harnessed serum metabolomics to discern potential diagnostic markers for AP and distinguish between its biliary (BAP) and alcohol-induced (AAP) forms. Leveraging high-performance liquid chromatography coupled with mass spectrometry, the metabolic signatures of 34 AP patients were contrasted against 26 healthy participants, and then between different etiologies of AP. The results identified metabolites primarily from glycerophospholipids, glycerolipids, fatty acyls, sterol lipids, and pteridines and derivative classes, with the Human Metabolome Database aiding in classification. Notably, these metabolites differentiated AP from healthy states with high AUROC values above 0.8. Another set of metabolites revealed differences between BAP and AAP, but these results were not as marked as the former. This lipidomic analysis provides an introduction to the metabolic landscape of acute pancreatitis, revealing changes in multiple lipid classes and metabolites and identifying these metabolites. Future research could add and discover new diagnostic biomarkers and therapeutic strategies enhancing the management of acute pancreatitis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available